spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search    

The fully linked HTML version of this article has now been published.
JCS ePress online publication date 5 Aug 2003
doi: 10.1242/jcs.00694

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jcs.00694v1
116/18/3803    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levchenko, T.
Right arrow Articles by Holmgren, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levchenko, T.
Right arrow Articles by Holmgren, L.

Research Article

Loss of responsiveness to chemotactic factors by deletion of the C-terminal protein interaction site of angiomotin


Tetyana Levchenko, Karin Aase, Boris Troyanovsky, Anders Bratt, and Lars Holmgren*
* Author for correspondence (e-mail: lars.holmgren{at}cck.ki.se)

We have recently identified a novel protein, named angiomotin, by its ability to bind the angiogenesis inhibitor angiostatin in the yeast two-hybrid system. Angiomotin belongs to a family with two other members, AmotL-1 and -2 characterized by coiled-coil and C-terminal PDZ binding domains. Here we show that the putative PDZ binding motif of angiomotin serves as a protein recognition site and that deletion of three amino acids in this site results in inhibition of chemotaxis. Furthermore, endothelial cells expressing mutant angiomotin failed to migrate and form tubes in an in vitro tube formation assay. To study the effect of angiomotin on embryonic angiogenesis, we generated transgenic mice expressing wild-type angiomotin and the C-terminal deletion mutant driven by the endothelial cell-specific receptor tyrosine kinase (TIE) promoter. Expression of mutant angiomotin in endothelial cells inhibited migration into the neuroectoderm and intersomitic regions resulting in death at embryonic day 9.5. In contrast, mice expressing wild-type angiomotin developed normally and were fertile. These results suggest that the putative PDZ binding motif of angiomotin plays a critical role in regulating the responsiveness of endothelial cells to chemotactic cues.


This article has been cited by other articles:


Home page
 FASEB J.Home page
T. Levchenko, N. Veitonmaki, A. Lundkvist, H. Gerhardt, Y. Ming, K. Berggren, A. Kvanta, R. Carlsson, and L. Holmgren
Therapeutic antibodies targeting angiomotin inhibit angiogenesis in vivo
FASEB J, March 1, 2008; 22(3): 880 - 889.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
K. Aase, M. Ernkvist, L. Ebarasi, L. Jakobsson, A. Majumdar, C. Yi, O. Birot, Y. Ming, A. Kvanta, D. Edholm, et al.
Angiomotin regulates endothelial cell migration during embryonic angiogenesis
Genes & Dev., August 15, 2007; 21(16): 2055 - 2068.
[Abstract] [Full Text] [PDF]

Home page
 GENES CELLSHome page
Y. Sugihara-Mizuno, M. Adachi, Y. Kobayashi, Y. Hamazaki, M. Nishimura, T. Imai, M. Furuse, and S. Tsukita
Molecular characterization of angiomotin/JEAP family proteins: interaction with MUPP1/Patj and their endogenous properties
Genes Cells, April 1, 2007; 12(4): 473 - 486.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
H. Huang, F.-I Lu, S. Jia, S. Meng, Y. Cao, Y. Wang, W. Ma, K. Yin, Z. Wen, J. Peng, et al.
Amotl2 is essential for cell movements in zebrafish embryo and regulates c-Src translocation
Development, March 1, 2007; 134(5): 979 - 988.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Holmgren, E. Ambrosino, O. Birot, C. Tullus, N. Veitonmaki, T. Levchenko, L.-M. Carlson, P. Musiani, M. Iezzi, C. Curcio, et al.
A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth
PNAS, June 13, 2006; 103(24): 9208 - 9213.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Bratt, O. Birot, I. Sinha, N. Veitonmaki, K. Aase, M. Ernkvist, and L. Holmgren
Angiomotin Regulates Endothelial Cell-Cell Junctions and Cell Motility
J. Biol. Chem., October 14, 2005; 280(41): 34859 - 34869.
[Abstract] [Full Text] [PDF]


© The Company of Biologists Ltd 2003